Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Find therapies in clinical trials near you – page 442

recruiting
3 968
countries
28
conditions
2 103

10 282 trials match your criteria

Non-small cell lung cancer

Not yet recruiting

Study to Compare Zongertinib with Standard Treatment for Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin

Osteoarthritis

Not yet recruiting

Study on the Safety and Effectiveness of PLX-PAD Cells for Patients with Mild to Moderate Knee Osteoarthritis

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Emiplacel

Colorectal cancer+4

Not yet recruiting

Study of INCB099280 and Adagrasib for Adults with Advanced Solid Tumors with KRASG12C Mutation

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Adagrasib

Hip arthroplasty+1

Not yet recruiting

Study on Temporarily Stopping Duloxetine, Sertraline, and Paroxetine in Patients with Hip or Knee Osteoarthritis Undergoing Surgery

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Citalopram

End stage renal disease

Not yet recruiting

Study on the Safety of Glucothera Plus for Children with End-Stage Kidney Disease Undergoing Peritoneal Dialysis

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Glucose Monohydrate

Urinary incontinence

Not yet recruiting

Study on the Effectiveness and Safety of Stem Cell Therapy for Urinary Incontinence in Patients After Prostate Surgery

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride

Hormone receptor positive HER2 negative breast cancer

Not yet recruiting

Study on the Effectiveness of Abemaciclib, Inavolisib, and Giredestrant in Patients with Early HR-positive/HER2-negative Breast Cancer

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib

Metastases to peritoneum

Not yet recruiting

Study of Radspherin® for Patients with Peritoneal Cancer from Colorectal Cancer After Surgery and Chemotherapy

InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Radium-224 Adsorbed In Calcium Carbonate Microparticles

Fungal infection

Not yet recruiting

Study on Posaconazole for Treating Fungal Infections in Children Under 2 Years

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Posaconazole

Haematological malignancy+1

Not yet recruiting

Study on the Safety and Effectiveness of Pembrolizumab, Favezelimab, and Vibostolimab for Children and Young Adults with Blood Cancers or Solid Tumors

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years
  • Substances:Favezelimab

Congenital absence of bile ducts

Not yet recruiting

Study on Obeticholic Acid for Children with Biliary Atresia After Kasai Procedure

Investigational
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years
  • Substances:Obeticholic Acid

Transitional cell carcinoma

Not yet recruiting

Study of BT8009 Alone or with Pembrolizumab for Patients with Advanced or Metastatic Bladder Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Avelumab

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.